Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Martin Steinbuck"'
Autor:
Thomas Williams, Martin Steinbuck, Peter DeMuth, Xavier Cabana-Puig, Erica Palmer, Mimi M Jung, Jeff Zhang, Christopher M Haqq
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/fff8e02658ab4c698c0cb776574c337e
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8403285c72d242edbebec5019efbedf1
Autor:
Martin Steinbuck, Peter DeMuth, Lochana Seenappa, Christopher Haqq, Aniela Jakubowski, Lisa McNeil
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/164231bfe70a4705a455b7f519ae8c93
Autor:
Vijayendra Dasari, Lisa McNeil, Kirrilee Beckett, Matthew Solomon, George Ambalathingal, Martin Steinbuck, Aniela Jakubowski, Lochana Seenappa, Erica Palmer, Jeff Zhang, Chris Haqq, Peter DeMuth, Rajiv Khanna
Recent emergence of a causal like between Epstein-Barr virus (EBV) and multiple sclerosis has generated considerable interest in the development of an effective vaccine against EBV. Here we describe a novel vaccine formulation based on a lymph node t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0db2b328c23a0fc62dc0b75a0b02cb0b
https://doi.org/10.21203/rs.3.rs-1763329/v1
https://doi.org/10.21203/rs.3.rs-1763329/v1
Autor:
Aniela Jakubowski, Martin Steinbuck, Lisa K. McNeil, Christopher M. Haqq, Peter C. Demuth, Lochana M. Seenappa
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background The SARS-CoV-2 pandemic’s public health, economic, and social impacts mandate urgent development of effective vaccines to contain or eradicate infection. To that end, we evaluated a novel amphiphile (AMP) vaccine adjuvant, AMP-CpG, compo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3088a68d59774584bebef70e94fe9644
https://doaj.org/article/164231bfe70a4705a455b7f519ae8c93
https://doaj.org/article/164231bfe70a4705a455b7f519ae8c93
Autor:
Aniela Jakubowski, Christopher M. Haqq, Martin Steinbuck, Lisa K. McNeil, Peter C. Demuth, Lochana M. Seenappa
Publikováno v:
Science Advances
Lymph node–targeting adjuvant AMP-CpG enhances SARS-CoV-2 RBD vaccine-induced cellular and humoral immune responses.
The profound consequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mandate urgent development of effect
The profound consequences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mandate urgent development of effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d963ee7814568acb3d846255583d1615
https://pubmed.ncbi.nlm.nih.gov/33547083
https://pubmed.ncbi.nlm.nih.gov/33547083
Autor:
Peter C. Demuth, Lisa K. McNeil, Christopher M. Haqq, Martin Steinbuck, Aniela Jakubowski, Lochana M. Seenappa
The SARS-CoV-2 pandemic has led to public health, economic, and social consequences that mandate urgent development of effective vaccines to contain or eradicate infection. To that end, we evaluated a novel amphiphile (AMP) vaccine adjuvant, AMP-CpG,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90d50730c4dcc4638c13764f2b6a6532
https://doi.org/10.1101/2020.08.17.251728
https://doi.org/10.1101/2020.08.17.251728